搜索临床试验以:LVEF < 40%
总计3133个结果
-
Northwestern UniversityNational Cancer Institute (NCI); Boehringer Ingelheim; Robert H. Lurie Cancer Center主动,不招人复发性成人急性髓性白血病 | 难治性急性髓性白血病 | 具有 t(9;11)(p22.3;q23.3) 的急性髓系白血病; MLLT3-KMT2A | 成纤维细胞生长因子基本形式测量 | FLT3 内部串联复制美国
-
Universitätsklinikum Hamburg-EppendorfAbbott Medical Devices; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)完全的
-
Meir Medical CenterClalit Health Services; Reidman college未知
-
Laval University完全的
-
ANRS, Emerging Infectious DiseasesInstitut National de la Santé Et de la Recherche Médicale, France完全的
-
Wuling OuJiangsu HengRui Medicine Co., Ltd.; Hubei Clinical Research Collaboration Group未知
-
The Center for Rheumatic Disease, Allergy, & ImmunologyAstraZeneca完全的
-
Duke UniversityAmerican Heart Association终止
-
Centre Hospitalier Intercommunal Creteil主动,不招人
-
Betsi Cadwaladr University Health BoardOxford Brookes University招聘中
-
Novartis Pharmaceuticals完全的
-
University of SouthamptonBioNTech SE完全的
-
MedtronicNeuroMedtronic Bakken Research Center完全的
-
Aarhus University HospitalOdense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark; Bispebjerg Hospital 和其他合作者完全的
-
Zealand University HospitalUniversity of Copenhagen; Region Zealand未知
-
UroGen Pharma Ltd.完全的
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical Trials完全的